The Role of the Collateral Circulation in Stable Angina: An Invasive Placebo-Controlled Study

Christopher A Rajkumar1,2, Michael J Foley1,2, Fiyyaz Ahmed-Jushuf1,2

  • 1National Heart and Lung Institute, Imperial College London, London, UK (C.A.R., M.J.F., F.A.-J., S.C., F.A.S., M.M., A.S., S.G., R.P., G.D.C., J.P.H., D.P.F., M.J.S.-S., R.K.A.-L.).

Circulation
|October 27, 2025
PubMed

Insights

Coronary collateralization significantly reduces ischemic chest pain intensity in stable coronary artery disease patients. This study found that better collateral flow, not ischemia severity, correlated with less angina, suggesting a nonlinear relationship.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Ischemic Heart Disease

Background:

  • Stable coronary artery disease patients often show a disconnect between ischemia burden and angina severity.
  • Investigating the interplay between ischemia, collateral circulation, and symptoms is crucial.

Purpose of the Study:

  • To examine the relationship between ischemia, collateral circulation, and angina symptoms in stable coronary artery disease.
  • To explore if progressive collateral recruitment is linked to ischemic preconditioning.

Main Methods:

  • Fifty-one patients with severe single-vessel coronary artery disease and angina underwent pressure wire studies and coronary flow reserve assessment.
  • Participants experienced controlled balloon occlusions and placebo inflations, with daily symptom tracking via a smartphone app.
  • Collateral flow index was calculated during occlusion, and pain intensity was scored post-episode.

Main Results:

  • Angina frequency showed minimal correlation with ischemia severity (fractional flow reserve or instantaneous wave-free ratio).
  • Lower fractional flow reserve and instantaneous wave-free ratio values strongly correlated with greater collateral flow.
  • Increased collateralization (higher collateral flow index) was associated with lower reported pain intensity.

Conclusions:

  • Coronary collateralization is linked to reduced ischemic burden and may alleviate angina intensity.
  • These findings help explain the complex, nonlinear relationship between coronary stenosis, ischemia, and chest pain.
Abstract

Related Concept Videos

Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
284
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
232
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
322
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
197
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
210
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
1.3K